CQUniversity Unit Profile
BMSC13020 Drug Discovery and Clinical Trials
Drug Discovery and Clinical Trials
All details in this unit profile for BMSC13020 have been officially approved by CQUniversity and represent a learning partnership between the University and you (our student).
The information will not be changed unless absolutely necessary and any change will be clearly indicated by an approved correction included in the profile.
General Information

Overview

The development of new therapeutic products for the medical biotechnology industry requires comprehensive knowledge of techniques used to investigate their effects on various biological pathways at a cellular level. This unit will provide you with an opportunity to apply theoretical and practical knowledge of medical biotechnology, drug development and pre-clinical testing of a new therapeutic product for industry commercialisation. You will develop new practical skills and gain experience in experimental models used to study human disease and apply these in a simulated industry environment. Your practical skills and demonstration of professional knowledge, attitude and compliance with relevant safety protocols will be assessed in a laboratory environment. Attendance at the practical activities at a compulsory residential school is a requirement of this unit. You will also develop the skills to communicate your findings to a broader audience in the medical biotechnology industry through both written reports and oral presentations.

Details

Career Level: Undergraduate
Unit Level: Level 3
Credit Points: 6
Student Contribution Band: 8
Fraction of Full-Time Student Load: 0.125

Pre-requisites or Co-requisites

Pre-requisite: BMSC12010 Clinical Biochemistry

Important note: Students enrolled in a subsequent unit who failed their pre-requisite unit, should drop the subsequent unit before the census date or within 10 working days of Fail grade notification. Students who do not drop the unit in this timeframe cannot later drop the unit without academic and financial liability. See details in the Assessment Policy and Procedure (Higher Education Coursework).

Offerings For Term 1 - 2025

Mixed Mode
Rockhampton

Attendance Requirements

All on-campus students are expected to attend scheduled classes - in some units, these classes are identified as a mandatory (pass/fail) component and attendance is compulsory. International students, on a student visa, must maintain a full time study load and meet both attendance and academic progress requirements in each study period (satisfactory attendance for International students is defined as maintaining at least an 80% attendance record).

Class and Assessment Overview

Recommended Student Time Commitment

Each 6-credit Undergraduate unit at CQUniversity requires an overall time commitment of an average of 12.5 hours of study per week, making a total of 150 hours for the unit.

Class Timetable

Bundaberg, Cairns, Emerald, Gladstone, Mackay, Rockhampton, Townsville
Adelaide, Brisbane, Melbourne, Perth, Sydney

Assessment Overview

1. Practical Assessment
Weighting: Pass/Fail
2. Report
Weighting: 60%
3. Presentation
Weighting: 40%

Assessment Grading

This is a graded unit: your overall grade will be calculated from the marks or grades for each assessment task, based on the relative weightings shown in the table above. You must obtain an overall mark for the unit of at least 50%, or an overall grade of 'pass' in order to pass the unit. If any 'pass/fail' tasks are shown in the table above they must also be completed successfully ('pass' grade). You must also meet any minimum mark requirements specified for a particular assessment task, as detailed in the 'assessment task' section (note that in some instances, the minimum mark for a task may be greater than 50%). Consult the University's Grades and Results Policy for more details of interim results and final grades.

Previous Student Feedback

Feedback, Recommendations and Responses

Every unit is reviewed for enhancement each year. At the most recent review, the following staff and student feedback items were identified and recommendations were made.

Feedback from Student feedback, self reflection

Feedback

Students felt that the laboratory manual needed updating to better describe the experimental procedures.

Recommendation

The laboratory manual for the residential school should be updated to cover the experiments performed.

Feedback from Self reflection

Feedback

Lecturer feels that the tutorials need to be updated to better reflect the ongoing changes in the biotechnology area.

Recommendation

Consider updating the unit content to align with the changes that have occurred in the biotechnology field since COVID19.

Unit Learning Outcomes
On successful completion of this unit, you will be able to:
  1. Conduct molecular or cell-based tests used to study human disease
  2. Display professional behaviour consistent with the safety and ethical practices of the laboratory
  3. Critically analyse current scientific literature
  4. Think critically to solve problems during the development and testing of therapeutics
  5. Effectively communicate experimental findings to industry professionals through written reports and oral presentations.
Alignment of Learning Outcomes, Assessment and Graduate Attributes
N/A Level
Introductory Level
Intermediate Level
Graduate Level
Professional Level
Advanced Level

Alignment of Assessment Tasks to Learning Outcomes

Assessment Tasks Learning Outcomes
1 2 3 4 5
1 - Practical Assessment - 0%
2 - Report - 60%
3 - Presentation - 40%

Alignment of Graduate Attributes to Learning Outcomes

Graduate Attributes Learning Outcomes
1 2 3 4 5
1 - Communication
2 - Problem Solving
3 - Critical Thinking
4 - Information Literacy
5 - Team Work
6 - Information Technology Competence
7 - Cross Cultural Competence
8 - Ethical practice
9 - Social Innovation
10 - Aboriginal and Torres Strait Islander Cultures

Alignment of Assessment Tasks to Graduate Attributes

Assessment Tasks Graduate Attributes
1 2 3 4 5 6 7 8 9 10
1 - Practical Assessment - 0%
2 - Report - 60%
3 - Presentation - 40%
Textbooks and Resources

Textbooks

There are no required textbooks.

IT Resources

You will need access to the following IT resources:
  • CQUniversity Student Email
  • Internet
  • Unit Website (Moodle)
Referencing Style

All submissions for this unit must use the referencing styles below:

For further information, see the Assessment Tasks.

Teaching Contacts
Noor Jarbou Unit Coordinator
n.jarbou@cqu.edu.au
Schedule
Week 1 Begin Date: 10 Mar 2025

Module/Topic

Topic 1: Pharmaceutical Industry, Drivers and Stages of Drug Development

Chapter

Events and Submissions/Topic

Week 2 Begin Date: 17 Mar 2025

Module/Topic

Topic 2: From Diseases to Drugs

Chapter

Events and Submissions/Topic

Week 3 Begin Date: 24 Mar 2025

Module/Topic

Topic 3: Preclinical Toxicity

Chapter

Events and Submissions/Topic

Week 4 Begin Date: 31 Mar 2025

Module/Topic

Topic 4: Clinical Phase I Trials

Chapter

Events and Submissions/Topic

Week 5 Begin Date: 07 Apr 2025

Module/Topic

Topic 5: Regulatory Agencies and Quality Regulations

Chapter

Events and Submissions/Topic

Vacation Week Begin Date: 14 Apr 2025

Module/Topic

Chapter

Events and Submissions/Topic

Week 6 Begin Date: 21 Apr 2025

Module/Topic

Topic 6: Clinical Phase II Trials - Informed Patient Consent and Pharmacovigilance

Chapter

Events and Submissions/Topic

Submit your topic for Assessment 1 by 12:00 PM on Thursday the 24th of April 2025.

Week 7 Begin Date: 28 Apr 2025

Module/Topic

Topic 7: Clinical Phase II Trials (cont) - Roles and Responsibilities

Chapter

Events and Submissions/Topic

Week 8 Begin Date: 05 May 2025

Module/Topic

Topic 8: Drug Manufacturing

Chapter

Events and Submissions/Topic

Week 9 Begin Date: 12 May 2025

Module/Topic

Topic 9: Clinical Phase III trials - Protocols

Chapter

Events and Submissions/Topic

Assessment 1 Due - Therapeutic Development Proposal (Monday 12th May)

Res School Begin Date: 19 May 2025

Module/Topic

Residential School. This is a compulsory laboratory session held at the Rockhampton campus.

Chapter

Events and Submissions/Topic

Assessment 2: Practical skills assessment


Assessment 1: THERAPEUTIC DEVELOPMENT PROPOSAL Due: Week 10 Friday (23 May 2025) 5:00 pm AEST
Week 11 Begin Date: 26 May 2025

Module/Topic

Topic 11: Clinical Phase III trials (cont)- Clinical Project Management, Blinding and Global Trials

Chapter

Events and Submissions/Topic

Assessment 3 Due - Conference Presentation (Friday 30 May)

Week 12 Begin Date: 02 Jun 2025

Module/Topic

Topic 12: Clinical Phase III trials (cont) - Ethics, Consultants and Medical Advisory Boards

Chapter

Events and Submissions/Topic

Assessment 3: CONFERENCE PRESENTATION Due: Week 12 Friday (6 June 2025) 5:00 pm AEST
Review/Exam Week Begin Date: 09 Jun 2025

Module/Topic

Chapter

Events and Submissions/Topic

Exam Week Begin Date: 16 Jun 2025

Module/Topic

Chapter

Events and Submissions/Topic

Term Specific Information

Unit Coordinator: Dr. Noor Jarbou
Email: n.jarbou@cqu.edu.au
Location: Building 6, 554-700 Yaamba Road, Rockhampton, QLD 4701
Phone: +61 7 4923 9894

Unit Delivery Instructions:

1- Lectures – Prerecorded and accessible at students' convenience.
2- Tutorials – Conducted live, scheduled based on student cohort availability.
3- Residential School – Attendance is mandatory on the Rockhampton campus.

Assessment Tasks

1 Practical Assessment

Assessment Title
ASSESSMENT 2: PRACTICAL LABORATORY SKILLS

Task Description

Laboratory-based (preclinical) testing of pharmaceuticals is essential to demonstrate the desired efficacy and biological activity in the treatment of various diseases. Employers within the biotechnology and medical research industries commonly use cell-based models of human disease and will be looking for graduates with a sound knowledge and practical training in such techniques. Hence, you will be assessed in this unit regarding your performance in undertaking these cell-based techniques, as described below.

During the Residential School, you will be provided with a pharmaceutical agent that has been recently discovered to have activity against cervical cancers. The hypothetical biotechnology company you are employed in has recently identified this agent from a plant that is indigenous to Australia and currently has little knowledge of how this drug works as an anti-cancer agent. Your task during the Residential School will be to undertake a series of experiments (as outlined in a Laboratory Manual provided on the Moodle site) to explore the anti-cancer properties and mechanism of action of this new potential treatment for cervical cancer. The below techniques will be used during the Residential School:

        1.        Culturing of mammalian cancer cells

        2.        Immunofluorescence microscopy

        3.        Quantitative real-time PCR

        4.        MTS assay

Sufficient training on both the practical and theoretical components of these procedures will be provided during the Residential School. You will complete each of these cell-based techniques (as outlined in the Laboratory Manual on the Moodle site for this unit) and will be assessed on the quality of the outcomes of these procedures. The assessment will be conducted as follows:

  • The unit coordinator will undertake the cell-based techniques in parallel with you as a benchmark of quality of the experimental output.
  • If your first attempt at the technique does not meet the minimum passing criteria, you will be allowed a subsequent maximum of (two) attempts at this technique.
  • you must be deemed competent in all competencies assessed during the residential school (Competency form can be located on the Moodle page).

Gen AI Use Statement:

According to CQU guideline regarding the use of Generative AI in assessments, students are allowed to use Gen AI for:

1- Developing literature search strategies
2- Guidance on arguments
3- Formatting and grammar assistance

If you’re planning to use AI-generated content in your work, you'll need to:

1- Declaration Statement – Include the following on the front page of your submission:
"I have used (insert technology) to (insert how you used it) in accordance with this unit's requirements. The reason I used this was to (explain why). The details of how I used it are (insert how). I declare that this submission represents my individual skills and abilities to meet the task requirements."
2- Citations – Fact-check AI-generated content, cite primary sources and the AI tool used.
3- Appendix – Include AI prompts and responses. Missing this may lead to an academic integrity review.


Assessment Due Date

Assessment of practical skills will be completed during the residential school


Return Date to Students

Assessment of practical skills will be discussed during the residential school


Weighting
Pass/Fail

Assessment Criteria

A Pass / Fail grade will be awarded depending on the level of competency and knowledge displayed during the Practical
Assessment. If a fail grade is awarded, students will be allowed a second attempt at the practical assessment during the

You must pass the Practical Assessment to be eligible to pass the unit.

You will be assessed on the following criteria:

  • Aseptic culture techniques
  • Adequate labeling of experimental samples
  • Quality of preparing the samples
  • Quality of microscopy images
  • Quality of quantitative real-time PCR results
  • Analysis and interpretation of real-time PCR data
  • Analysis and interpretation of the TUNEL assay results
  • Analysis and interpretation of the MTS assay results

 


Referencing Style

Submission

No submission method provided.


Submission Instructions
You will be assessed on your practical skills during the Residential School

Learning Outcomes Assessed
  • Conduct molecular or cell-based tests used to study human disease
  • Display professional behaviour consistent with the safety and ethical practices of the laboratory


Graduate Attributes
  • Critical Thinking
  • Ethical practice

2 Report

Assessment Title
Assessment 1: THERAPEUTIC DEVELOPMENT PROPOSAL

Task Description

Assessment: Proposal for a Novel Therapeutic

The lecture content from Weeks 1 to 8 will provide you with foundational knowledge on how potential therapeutics are developed and translated into clinical trials within the biotechnology industry. To reinforce this learning, lectures will include specific case studies to illustrate real-world applications.

For this assessment, you will apply this knowledge by surveying existing literature on similar case studies and developing your own potential new therapeutic.

Project Overview:

You will:

1- Select a specific disease with a key “driver” that is targetable by pharmaceuticals.
This may be a disease without current treatments or one where existing treatment could be improved.
2- Confirm your disease selection with the Unit Coordinator by Thursday of Week 6.
3- Develop a written proposal addressing the following sections:

  • Part A: Target Patient Population & Disease Characteristics
    1- Who is your target patient population?
    2- What are the key characteristics of the disease that your therapeutic aims to target?
    3- Identify the specific biological or genetic abnormalities relevant to your drug’s mechanism of action (e.g., gene mutations, biochemical imbalances).
  • Part B: Pre-Clinical Disease Models
    1- Which pre-clinical models (e.g., cell lines, organoids, animal models) would you propose for testing your therapeutic?
         Justify your choice based on disease pathophysiology and relevance to human conditions.
  • Part C: Pre-Clinical Toxicity Study
    1- Outline a pre-clinical toxicity study for your therapeutic.
    2- Consider factors such as dosage, duration, target organs, and potential side effects. 

Formatting & Submission Guidelines:

1- Word count: 2,000 – 2,500 words
2- Formatting:
    - Use Microsoft Word or another standard word processor
    - Figures, diagrams, or tables should be included where relevant with scientific legends
    - Save and submit as a PDF

3- Referencing:
   - Scientific references are essential
   - Use APA, or Harvard referencing style

This proposal should be an opportunity to demonstrate your understanding of drug development, literature research, and critical analysis of pre-clinical testing methods.

Gen AI Use Statement:

According to CQU guideline regarding the use of Generative AI in assessments, students are allowed to use Gen AI for:

1- Developing literature search strategies
2- Guidance on arguments
3- Formatting and grammar assistance

If you’re planning to use AI-generated content in your work, you'll need to:

1- Declaration Statement – Include the following on the front page of your submission:
"I have used (insert technology) to (insert how you used it) in accordance with this unit's requirements. The reason I used this was to (explain why). The details of how I used it are (insert how). I declare that this submission represents my individual skills and abilities to meet the task requirements."
2- Citations – Fact-check AI-generated content, cite primary sources and the AI tool used.
3- Appendix – Include AI prompts and responses. Missing this may lead to an academic integrity review.


Assessment Due Date

Week 10 Friday (23 May 2025) 5:00 pm AEST


Return Date to Students

2 weeks after submission


Weighting
60%

Minimum mark or grade
50%

Assessment Criteria

The assessment of this written report will be based on the demonstrated knowledge of disease mechanisms and therapeutic targets, rationalization and justification of your arguments and ideas, support of these arguments and ideas using appropriate robust scientific literature and clarity of the proposal with accurate referencing, 

A detailed marking rubric and an assessment structure template will be available on the Moodle site for this unit.


Referencing Style

Submission
Online

Submission Instructions
Please submit as a pdf file using the Moodle Assessment Submission Site.

Learning Outcomes Assessed
  • Critically analyse current scientific literature
  • Think critically to solve problems during the development and testing of therapeutics
  • Effectively communicate experimental findings to industry professionals through written reports and oral presentations.


Graduate Attributes
  • Communication
  • Problem Solving
  • Critical Thinking

3 Presentation

Assessment Title
Assessment 3: CONFERENCE PRESENTATION

Task Description

Presentation of your research findings at scientific meetings or conferences will ensure dissemination of your discoveries to the broader scientific community. In this assessment, your task is to present research findings on the specific anti-cancer drug that you were using during residential school. The oral presentation of your research findings will begin with your experimental results that you achieved during the residential school. You will then present a series of logical subsequent experiments and anticipated results to conclusively determine the mechanism of action of this relatively unknown anti-cancer drug. You will refer to recent scientific literature in this field to design these subsequent experiments in an effort to draw robust conclusions on the mechanism of action of this drug. It is expected that the volume of experimental findings presented (and proposed) during this presentation will be sufficient for publication in a scientific journal (approximately 6 to 8 figures).

Please note that the presentation can be between 10-15 minutes in duration. It can be recorded and uploaded into the Moodle Assessment Submission Site. It should follow the below sections:

  • Introduction regarding the discovery of the drug and target patient population.
  • Presentation of methods used at Residential School
  • Experimental results achieved during Residential School
  • Presentation of proposed subsequent experiments and anticipated results
  • Conclusion drawn from existing results (from Residential School) and from proposed experiments

The presentation can be prepared using any standard presentation software (for example, PowerPoint or Keynote). Links to recording software and instructions for how to record the presentation will be available on the Moodle site.

Gen AI Use Statement:

According to CQU guideline regarding the use of Generative AI in assessments, students are allowed to use Gen AI for:

1- Developing literature search strategies
2- Guidance on arguments
3- Formatting and grammar assistance

If you’re planning to use AI-generated content in your work, you'll need to:

1- Declaration Statement – Include the following on the front page of your submission:
"I have used (insert technology) to (insert how you used it) in accordance with this unit's requirements. The reason I used this was to (explain why). The details of how I used it are (insert how). I declare that this submission represents my individual skills and abilities to meet the task requirements."
2- Citations – Fact-check AI-generated content, cite primary sources and the AI tool used.
3- Appendix – Include AI prompts and responses. Missing this may lead to an academic integrity review.


Assessment Due Date

Week 12 Friday (6 June 2025) 5:00 pm AEST


Return Date to Students

2 weeks after submission


Weighting
40%

Minimum mark or grade
50%

Assessment Criteria

You will be assessed on the following criteria:

  • Clearly introduce the background information regarding the drug and accurately identify and describe the characteristics of the target patient population.
  • Accurate and clear presentation of methodology (both from existing protocols used at Residential School and subsequent proposed experiments).
  • Coherent and logical presentation of results in tabular or graphical format.
  • Clear presentation of microscopy images with accurate labeling.
  • Logical discussion of results with accurate and definitive conclusion outlined.
  • Appropriate use of referencing of scientific literature.

A detailed marking rubric will be available on the Moodle site for this unit.


Referencing Style

Submission
Online

Learning Outcomes Assessed
  • Critically analyse current scientific literature
  • Think critically to solve problems during the development and testing of therapeutics
  • Effectively communicate experimental findings to industry professionals through written reports and oral presentations.


Graduate Attributes
  • Communication
  • Problem Solving
  • Critical Thinking

Academic Integrity Statement

As a CQUniversity student you are expected to act honestly in all aspects of your academic work.

Any assessable work undertaken or submitted for review or assessment must be your own work. Assessable work is any type of work you do to meet the assessment requirements in the unit, including draft work submitted for review and feedback and final work to be assessed.

When you use the ideas, words or data of others in your assessment, you must thoroughly and clearly acknowledge the source of this information by using the correct referencing style for your unit. Using others’ work without proper acknowledgement may be considered a form of intellectual dishonesty.

Participating honestly, respectfully, responsibly, and fairly in your university study ensures the CQUniversity qualification you earn will be valued as a true indication of your individual academic achievement and will continue to receive the respect and recognition it deserves.

As a student, you are responsible for reading and following CQUniversity’s policies, including the Student Academic Integrity Policy and Procedure. This policy sets out CQUniversity’s expectations of you to act with integrity, examples of academic integrity breaches to avoid, the processes used to address alleged breaches of academic integrity, and potential penalties.

What is a breach of academic integrity?

A breach of academic integrity includes but is not limited to plagiarism, self-plagiarism, collusion, cheating, contract cheating, and academic misconduct. The Student Academic Integrity Policy and Procedure defines what these terms mean and gives examples.

Why is academic integrity important?

A breach of academic integrity may result in one or more penalties, including suspension or even expulsion from the University. It can also have negative implications for student visas and future enrolment at CQUniversity or elsewhere. Students who engage in contract cheating also risk being blackmailed by contract cheating services.

Where can I get assistance?

For academic advice and guidance, the Academic Learning Centre (ALC) can support you in becoming confident in completing assessments with integrity and of high standard.

What can you do to act with integrity?